Session Details

F035 Where do We Stand? The Pathogenesis and Treatment of Melasma

Sat, Mar 8, 1:00 PM - 3:00 PM
W202C
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Melasma is a global disorder of major cosmetic significance. It negatively impacts the quality of life of patients. The pathogenesis of melasma is complex. Multiple recent studies document the interplay of genetics, inflammation, oxidative stress, abnormal vascular responses, senescent fibroblasts, and sensitivity to hormones in the pathogenesis of the disorder. Recent data suggest that it is a phenotype of photodamage. Multiple new therapies offer significant improvement. This forum will review the most recent global advances in pathogenesis and treatment of melasma. Therapies reviewed will include photoprotection, topical and oral agents, chemical peels, microneedling, PRP, lasers, light sources and emerging therapies.

LEARNING OBJECTIVES

1.

Succinctly summarize new data on the epidemiology and pathogenesis of melasma.

2.

Review new data regarding photo protection strategies and treatment options including topical and oral agents, and resurfacing modalities.

3.

Discuss case-based algorithms and best practices for managing patients with this therapeutically challenging condition.

SCHEDULE

6:00 PM

Introduction

Pearl E. Grimes, MD, FAAD

6:05 PM

The Epidemiology and Pathogenesis of Melasma: The Winding Road of Discovery

Pearl E. Grimes, MD, FAAD

6:20 PM

The New Science of Photoprotection

Thierry Passeron, MD, PhD

6:35 PM

The Landscape of Topical Therapies

Nada Elbuluk, MD, FAAD

6:47 PM

Topical Therapies: New Paradigms

Heather Clare Woolery-Lloyd, MD, FAAD

7:00 PM

Oral Therapies for Melasma

Seemal R. Desai, MD, FAAD

7:15 PM

Chemical Peeling, Microneedling, and PRP Best Practices

Rashmi Sarkar, MD, IFAAD

7:30 PM

Lasers and Energy Based Devices

Arielle N.B. Kauvar, MD, FAAD

7:45 PM

Q&A

SPEAKERS

Seemal R. Desai, MD, FAAD

Seemal R. Desai, MD, FAAD

Nada Elbuluk, MD, FAAD

Nada Elbuluk, MD, FAAD

Pearl E. Grimes, MD, FAAD

Pearl E. Grimes, MD, FAAD

Arielle N.B. Kauvar, MD, FAAD

Arielle N.B. Kauvar, MD, FAAD

Thierry Passeron, MD, PhD

Thierry Passeron, MD, PhD

Rashmi Sarkar, MD, IFAAD

Rashmi Sarkar, MD, IFAAD

Heather Clare Woolery-Lloyd, MD, FAAD

Heather Clare Woolery-Lloyd, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Seemal R. Desai, MD, FAAD

AbbVie – Consultant(Fees), Speaker(Fees); Allergan, Inc – Consultant(Fees); Amgen – Consultant(Fees); Apogee Therapeutics – Consultant(Fees); Atacama Therapeutics – Investigator(Grants/Research Funding); Avita – Consultant(Fees); Ballature Beauty – Consultant(Fees); Beiersdorf, Inc. – Consultant(Fees); Bristol-Myers Squibb – Consultant(Fees); Candela Corporation – Consultant(Fees); Cassiopea S.p.A. – Consultant(Fees); Castle Biosciences – Consultant(Fees); Cutera, Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Ferndale Laboratories, Inc. – Consultant(Honoraria); Foamix – Consultant(Fees); Foundation for Research & Education of Dermatology – Advisory Board(Fees); Galderma Laboratories, LP – Consultant(Fees), Speaker(Honoraria); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Gore Range Capital – Consultant(Stock Options), Stockholder(Stock Options); Hyphens Pharma – Consultant(Fees); Illuminate Skin Care LLC – Founder(Other Financial Benefit); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); International Society of Dermatology – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Fees); Johnson and Johnson – Consultant(Fees); L'Oreal USA Inc. – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees); Lyceum Health – Consultant(Fees); Medscape – Other(Fees); National Psoriasis Foundation – Other(No Compensation Received); Ortho Dermatologics – Consultant(Fees); PDH Holdings LLC – Other(No Compensation Received); Pfizer Inc. – Consultant(Fees), Speaker(Honoraria); Revision Skincare – Consultant(Fees); Sanofi/Regeneron – Consultant(Fees); Scientis – Consultant(Fees); Skin Science Advisors – Consultant(Fees); SkinMedica, Inc. – Investigator(Grants/Research Funding); UCB – Consultant(Fees); Verrica Pharmaceuticals Inc – Consultant(Fees); VYNE Therapeutics – Consultant(Fees); Womens Derm Society – Board of Directors(No Compensation Received);

Nada Elbuluk, MD, FAAD

AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees); Galderma Laboratories, L.P. – Advisory Board(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Advisory Board(Fees); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Medscape – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); VisualDx – Consultant(Fees), Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);

Pearl E. Grimes, MD, FAAD

AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);

Arielle N.B. Kauvar, MD, FAAD

Candela Corporation – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding);

Thierry Passeron, MD, PhD

AbbVie – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria); Amgen – Consultant(Honoraria); Astellas Pharma US, Inc – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Speaker(Honoraria); Bioderma – Speaker/Faculty Education(Honoraria); Celgene Corporation – Investigator(Grants/Research Funding); Cutera, Inc. – Advisory Board(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria); GlaxoSmithKline – Speaker/Faculty Education(Honoraria); Hyphens Pharma – Speaker/Faculty Education(Honoraria); Incyte Corporation – Investigator(Fees), Speaker/Faculty Education(Honoraria); ISDIN – Advisory Board(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Journal of the European Academy of Dermatology and Venereology – Other(No Compensation Received); L'Oréal Research and Innovation – Speaker/Faculty Education(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria); Leo Pharma Inc. – Speaker/Faculty Education(Honoraria); Lilly ICOS LLC – Speaker/Faculty Education(Honoraria); Mesoestetic USA Laboratories – Advisory Board(Honoraria); MSD – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker/Faculty Education(Honoraria); Symrise – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria), Speaker(Honoraria); VYNE Therapeutics – Advisory Board(Honoraria);

Rashmi Sarkar, MD, IFAAD

No financial relationships exist with ineligible companies.

Heather Clare Woolery-Lloyd, MD, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Other Financial Benefit); Allergan, Inc. – Investigator(Other Financial Benefit); Arcutis Biotherapeutics – Advisory Board(Honoraria); Avita – Investigator(Grants/Research Funding); Beiersdorf – Speaker(Fees); Eirion Therapeutics – Investigator(Other Financial Benefit); Eli Lilly and Company – Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Other Financial Benefit); Incyte Corporation – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Johnson & Johnson Consumer Products Company – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); L’Oréal – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Investigator(Other Financial Benefit); SC Johnson – Consultant (1099 relationship)(Fees); TEOXANE Laboratories – Investigator(Grants/Research Funding);